Streetbeat News

Stock Prices

SNV

Synovus Financial Corp (NYSE:SNV) has seen varied analyst ratings over the last three months, with a mix of bullish to bearish perspectives among 22 analysts. The average 12-month price target is $41.82, a decrease from the previous $43.90. Analyst actions include both upgrades and downgrades, reflecting dynamic market conditions and company performance. Synovus Financial offers a range of banking services and has shown a negative revenue trend with a -7.92% growth over three months, a net margin of 21.35%, and an ROE of 2.53%. The company's market capitalization is below industry benchmarks, indicating potential growth challenges.

Portfolio Pulse from Benzinga Insights

May 07, 2024 | 9:01 pm

RPTX

Repare Therapeutics (NASDAQ:RPTX) reported Q1 earnings of $0.30 per share, surpassing the $0.02 estimate, a 136.14% increase from last year's losses. Sales reached $52.40M, beating the $38.40M estimate, marking an 822.93% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 9:01 pm

CLPT

ClearPoint Neuro (NASDAQ:CLPT) reported Q1 2024 earnings with a smaller loss per share of $(0.16) compared to the expected $(0.19), and sales of $7.639M, surpassing the $6.994M estimate. This represents a significant improvement over the previous year, with a 30.43% decrease in losses and a 40.60% increase in sales.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 9:01 pm

LYFT

Lyft's stock price increased after the company reported mixed results for the first quarter.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 9:00 pm

SSNT

SilverSun Technologies (NASDAQ:SSNT) reported a decrease in Q1 EPS to $0.03 from $0.05 YoY, while sales increased to $14.44M from $13.13M YoY.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:59 pm

RYAM

Rayonier Advanced Materials (RYAM) reported Q1 2024 adjusted EPS of $(0.02), surpassing the $(0.10) estimate, but its sales of $388M fell short of the $429.7M forecast. This represents a 140% decrease in EPS and a 16.92% drop in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:59 pm

MCHX

Marchex shares are trading higher following the announcement of their Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:59 pm

NVRO

Nevro (NYSE:NVRO) reported Q1 2024 earnings with a GAAP EPS of $(0.70), surpassing the $(1.08) estimate, and sales of $101.899M, exceeding the $97.892M estimate. This represents a 28.57% improvement in EPS and a 5.78% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:59 pm

INOD

Innodata shares are trading higher following the announcement of improved Q1 financial results compared to the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:58 pm

HRT

HireRight Holdings (NYSE:HRT) reported Q1 earnings of $0.22 per share, surpassing the $0.20 estimate, marking a 22.22% increase from last year. However, their Q1 sales of $173.20M fell short of the $176.95M estimate, a 1.25% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 07, 2024 | 8:57 pm